Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Psoriasis Sprays: Niche Opportunities?

Executive Summary

Expanding treatment options for psoriasis highlight how some firms are developing innovative "lower risk" assets that use established active ingredients but could provide benefits to specific patient segments.

Advertisement

Related Content

Dr Reddy's COO On US Derma Build-Up, One-Sided Biologics Norms
Dr Reddy's Infuses Life Into XenoPort's Psoriasis Drug
To The East! Leo Pharma CEO On Global Ambitions And Astellas Buy
INTERVIEW: Dr Reddy's CEO on the 'windshield and rear view mirror'

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC065358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel